Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00246012 · ClinicalTrials.gov registry record · Phase 1

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

A Phase 1 study of Melanoma, sponsored by Centocor.

Completed
Registry status
Phase 1
Development phase
144
Enrollment target
20
Study locations

NCT00246012 is a Phase 1 study of Melanoma that has completed, run by Centocor. The registered enrollment target is 144 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00246012, a Phase 1 study of Melanoma, has completed, sponsored by Centocor.

COMPLETED
Registry status
Phase 1
Development phase
144 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the intetumumab, alone and in combination with dacarbazine, in patients with stage 4 melanoma.

Conditions Studied

Melanoma

Interventions

  • DRUG Placebo
  • DRUG Dacarbazine
  • DRUG Intetumumab

Study Locations (20)

California

  • - La Jolla
  • - Santa Monica
  • - Walnut Creek

Other

  • - Berlin
  • - Bonn
  • - Buxtehude

New York

  • - Buffalo
  • - New York

Arizona

  • - Scottsdale

Colorado

  • - Aurora

District of Columbia

  • - Washington D.C.

Florida

  • - Miami

Georgia

  • - Atlanta

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2005-05
Est. Completion 2009-02
Phase Phase 1

Sponsor

Centocor

33 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00246012

The ClinicalTrials.gov registry entry for NCT00246012 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (80% lower). The listed sponsor is Centocor, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00246012 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Other, New York.

Frequently Asked Questions

What is clinical trial NCT00246012 about?

NCT00246012 is a clinical study titled "A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma". The purpose of this study is to evaluate the safety and effectiveness of the intetumumab, alone and in combination with dacarbazine, in patients with stage 4 melanoma.

What is the current status of trial NCT00246012?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 144 participants. The study started on 2005-05. Estimated completion is 2009-02.

What conditions does trial NCT00246012 study?

This clinical trial studies the following conditions: Melanoma.

What interventions are being tested in trial NCT00246012?

The interventions under investigation include: Placebo (DRUG), Dacarbazine (DRUG), Intetumumab (DRUG).

Who is sponsoring clinical trial NCT00246012?

This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00246012 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.